3035 examinations were performed at the newly-opened Mammography Unit of the Department of Radiology, Semmelweis University, Budapest in 1976 and 1977. Most of the examined persons presented themselves voluntarily and had some kind of complaints. 153 cases of breast cancer were detected and operated. 86% of the breast cancer patients had objective signs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A quasi-experimental study of general practices' referral to mammography in the post-trials treatment era.
Epidemiology
January 2025
Department of Public Health, Aarhus University, Aarhus, DK.
Background: Improvements in breast cancer therapy since the randomized controlled trials of mammography screening might have reduced the screening benefit. Most observational studies of mammography effectiveness would be confounded by these improvements and other factors. Using a design resistant to this confounding, we evaluated whether mammography in asymptomatic women reduces breast cancer mortality during the treatment era succeeding the trials.
View Article and Find Full Text PDFA straightforward method for assessing the technical image quality of reconstructed and synthetic 2D images for Digital breast tomosynthesis systems.
Phys Med
January 2025
Medical Physics Unit, ASST Monza, Monza, Italy.
Purpose: Digital Breast Tomosynthesis (DBT) is an advanced mammography technique for which there are currently no internationally agreed methods and reference values for image quality assessment. The aim of this multicentre study was to evaluate a simple method to assess the technical image quality of reconstructed and synthetic 2D (SM) images of different models of DBT systems using commercially available phantoms.
Methods: The signal difference to noise ratio (SDNR) was chosen as an index of technical image quality and was evaluated for three commercial phantoms, Tomophan, Tormam and CIRS model 015, on 55 DBT systems (six vendors, nine models).
Lombardy Region: seven years of breast cancers screening before, during and after the SARS-CoV-2 pandemic.
Ann Ig
January 2025
Department of Biomedical Sciences for Health, University of Milan, Italy.
Background: Breast cancer represents the most common form of neoplasm in women, with an estimated 685,000 deaths annually. In this regard, screening programmes represent one of the most effective intervention tools in the field of cancer prevention. The aim of this study is to analyse and describe the key performance indicators of the screening programmes in Lombardy from 2016 to 2022.
View Article and Find Full Text PDFTumour growth rate and invasive interval cancer characteristics in a UK breast cancer screening population.
Eur Radiol
January 2025
Department of Radiology, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Objectives: To estimate tumour volume doubling time (TVDT) of interval cancers (ICs).
Methods: Two radiologists retrospectively reviewed prior screening and diagnostic mammograms and measured mean diameter on "visible" ICs. Univariate analyses of clinicopathological variables (ER, HER2, grade, age at diagnosis, and breast density) were undertaken, and those with p < 0.
Breast cancer classification in point-of-care ultrasound imaging-the impact of training data.
J Med Imaging (Bellingham)
January 2025
Lund University, Centre for Mathematical Sciences, Division of Computer Vision and Machine Learning, Lund, Sweden.
Purpose: The survival rate of breast cancer for women in low- and middle-income countries is poor compared with that in high-income countries. Point-of-care ultrasound (POCUS) combined with deep learning could potentially be a suitable solution enabling early detection of breast cancer. We aim to improve a classification network dedicated to classifying POCUS images by comparing different techniques for increasing the amount of training data.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!